Project Grant W81XWH2110141
Award Date
2/15/21
Completion Date
8/14/23
Dollars Obligated
$330K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02118, USA
Similar Awards
The Department of Defense's Defense Health Agency has awarded a $866,250 Project Grant to the Trustees of Boston University, doing business as the Boston University Medical Campus, under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2024, will fund a research project titled "TARGETING TRANSCRIPTIONAL NETWORKS DIRECTING IMMUNE EVASION IN PROGRESSIVE BRONCHIAL PREMALIGNANT LESIONS" through June 30, 2027. As a leading private research...
The Defense Health Agency awarded a $1,003,336 Project Grant to Trustees of Boston University under the Military Medical Research and Development program (CFDA 12.420) to investigate the "CONTRIBUTION OF CELLULAR SENESCENCE AND BRAIN AGING TO COGNITIVE DYSFUNCTION IN GWI" over a 3-year period from September 2023 to September 2026. As a leading private research institution, Boston University's Trustees will conduct biomedical research to transform healthcare for Service Members,...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $330,000 project grant to Trustees of Boston University, doing business as the Boston University Medical Campus. The grant, awarded on March 15, 2024, will fund research to enhance lymphatic function using transplanted muscle cells after bacterial infection. The research aims to improve medical care for military service members, veterans, and their families. Boston University, a leading...
This Project Grant award, funded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), provides $1,704,652.00 to Trustees of Boston University (Boston University Medical Campus) to conduct research on the translational impact of genetic susceptibility to complex toxic exposures on blood-brain barrier function and age-related neurological outcomes in Gulf War Illness (GWI). The award period runs from September 1, 2024 to August...
This $691,213 Project Grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports research into bioengineered 3D human brain systems to investigate risk factors, mechanisms, and treatments for traumatic brain injury-induced Alzheimer's disease. Tufts University is the primary awardee and will conduct research. Massachusetts General Hospital will provide $691,213 in research services as a sub-awardee. The overarching...
The Defense Health Agency awarded a $781,300.00 Project Grant titled "RELATIONSHIP OF METAL EXPOSURES TO HEALTH RISK MARKERS, MOOD, AND COGNITIVE FUNCTIONING IN MILITARY VETERANS" to Trustees of Boston University Medical Campus. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support research to investigate the relationship between metal exposures, health risk indicators, mood, and cognitive functioning in military veterans. Dartmouth...
The Department of the Army Medical Command awarded Boston University $999,636 under the Military Medical Research and Development federal grant program (CFDA 12.420) from July 1, 2022 to June 30, 2025. The award will support the identification of objective brain imaging biomarkers for Gulf War Illness through exposure- and symptom-specific markers, Gulf War illness subtypes, and longitudinal patterns. Dr. Steele of Baylor College of Medicine will collaborate with Boston University researchers on...
This federal Project Grant award for $628,292.00, granted by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research to investigate military-related toxic exposures as a risk factor for amyotrophic lateral sclerosis (ALS). The award was granted to the Boston VA Research Institute, Inc., a non-profit research organization affiliated with the VA Boston Healthcare System and academic institutions in the Boston area. The project will...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $713,277 to Boston University Medical Campus to conduct research on the translational impact of genetic susceptibility to complex toxic exposures on blood-brain barrier function and age-related neurological outcomes in Gulf War Illness. The award will support the project from September 1, 2024 through August 31, 2027. As part of this...
The Defense Health Agency awarded a $522,477 Project Grant to Boston Medical Center Corporation (BMC) under the Military Medical Research and Development program (CFDA 12.420). The funding will support research to define genetic vulnerabilities in pancreatic neuroendocrine tumors that rely on the alternative lengthening of telomeres pathway. This 3-year project grant runs from August 1, 2023 to July 31, 2026. A sub-award of an unspecified amount was provided to the Trustees of Boston...